# Nasal Fentanyl and Buccal Midazolam for Dying Patients

> **NCT02009306** · PHASE4 · COMPLETED · sponsor: **Gloucestershire Hospitals NHS Foundation Trust** · enrollment: 20 (actual)

## Conditions studied

- Terminal Cancer

## Interventions

- **DRUG:** PecFent and Epistatus
- **DRUG:** Standard subcutaneous medication
- **DRUG:** Epistatus Alone

## Key facts

- **NCT ID:** NCT02009306
- **Lead sponsor:** Gloucestershire Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-23
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-02-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02009306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02009306, "Nasal Fentanyl and Buccal Midazolam for Dying Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02009306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*